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Abstract: Immunocytes, mainly neutrophils and monocytes, exhibit an intrinsic homing 
property, enabling them to migrate to sites of injury and inflammation. They can thus act as 
Trojan horses carrying concealed drug cargoes while migrating across impermeable barriers 
to sites of disease, especially the blood–brain barrier (BBB). In this study, to target circulating 
phagocytic cells, we formulated negatively charged nanosize liposomes and loaded trefoil factor 3     
(TFF3) into liposomes by the pH-gradient method. According to the optimized formulation 
(5:1.5 of lipid to cholesterol, 10:1 of lipid to drug, 10 mg/mL of lipid concentration, and 
10 mmol/L of phosphate-buffered saline), 44.47% entrapment efficiency was obtained for TFF3 
liposomes with 129.6 nm particle size and -36.6 mV zeta potential. Compared with neutrally 
charged liposomes, the negatively charged liposomes showed a strong binding capacity with 
monocytes and were effectively carried by monocytes to cross the BBB in vitro. Furthermore, 
enhanced antidepressant-like effects were found in the tail-suspension and forced-swim tests 
in mice, as measured by decreased immobility time, as well as increased swimming time and 
reduced immobility in rats. These results suggested that negatively charged liposomes could 
improve the behavioral responses of TFF3, and our study opens up a new way for the develop-
ment of effective therapies for brain disease by increasing the permeability of the BBB.
Keywords: TFF3, drug delivery system, monocytes, brain-targeting drug delivery, antidepres-
sant, blood–brain barrier
Introduction
Depression is the most common mental disorder, and is increasingly recognized as a 
public health and social problem worldwide. A total of 4%–20% of the general popula-
tion will suffer from the disorder some time during their lifetime.1 Numerous studies 
have indicated that depression, as well as other mental illnesses, are closely associated 
with physical status.2 In the early 1990s, depression was reported for the first time as an 
illness characterized by cell-mediated immune activation. This observation developed 
into a novel hypothesis that inflammation and cell-mediated immune activation may 
be key factors in depression.3 Recent evidence suggests that depression is an inflam-
matory disorder because of the increased production of interleukin (IL)-1β, IL-6 and 
tumor necrosis factor (TNF)-α in people with depression.4
Despite breakthroughs in nanotechnology-based approaches, many brain diseases 
remain undertreated by effective therapies, because of the failure to deliver therapeutic 
compounds to the brain.5 The targeting of drugs within the brain is limited mainly 
by both the short plasmatic half-life of the therapeutic molecules and by the weak 
permeability of the blood–brain barrier (BBB).6 It was reported that inflammation in 
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the brain is found in several conditions, such as psychiatric 
diseases including depression.7 Immunocytes, mainly neu-
trophils and monocytes, exhibit an intrinsic homing property, 
enabling them to migrate to sites of injury and inflammation. 
Therefore, they can act as Trojan horses, carrying concealed 
drug cargoes while migrating across impermeable barriers 
to site of disease, especially the BBB.8
Using cells as delivery vehicles offers several advantages 
over common drug-administration regimens, including 
targeted drug transport and prolonged circulation times, 
along with reductions in cell and tissue toxicities.9 To target 
circulating phagocytic cells, negatively charged nanosize 
liposomes were formulated and exhibited an obvious brain-
targeting drug-delivery effect.10 The monocytes were identi-
fied as the main carriers for liposomes to the brain. Liposomes 
are one of the most successful drug-delivery systems, apply-
ing nanotechnology to potentiate the therapeutic efficacy and 
reduce toxicities of conventional medicines.11 Liposomes are 
round bubbles consisting of an aqueous core encapsulated 
by natural or synthetic phospholipids. This structure turns 
liposomes into ideal drug carriers. Hydrophilic drugs tend 
to be entrapped in the core, while hydrophobic ones will be 
entrapped within the lipid bilayers.
Trefoil factor 3 (TFF3), a member of the TFF family, is 
stable in the gastrointestinal tract but rapidly eliminated from 
the circulation.12–14 A study showing TFF3 injection induced 
Fos-positive cells in magnocellular oxytocin neurons in the 
hypothalamus promoted the research on the role of TFF3 in 
the central nervous system and related disorders.15 In spite of 
TFF3’s potential, the major challenge is its delivery across 
the BBB,16 which has been considered the most important 
barrier impeding the transport of drugs into the brain.5,17 
Therefore, an effective drug-delivery system for TFF3 to 
enhance its stability in plasma and uptake across the BBB 
has become urgent.
In the present study, negatively charged liposomes 
loaded with TFF3 (TFF3-Ls) were prepared for targeting the 
immunocytes in circulating blood, and were then delivered 
to lesions in the brain. Enhanced antidepressant-like effects 
were expected. Here, the characteristics, cellular uptake, 
targeting mechanism, and antidepressant-like effects of TFF3 
liposomes are examined.
Materials and methods
chemicals and reagents
DSPE-PEG (1,2-distearoyl-sn-glycero-3-phosphoetha-
nolamine-N-[amino(polyethylene-glycol)-2000]) (PEG 
molecular weight 2,000), distearoyl phosphatidyl glycerol 
(DSPG) and soybean phosphatidylcholine (SPC) was from 
Merck (99%; Schaffhausen, Switzerland). Cholesterol, Sep-
hadex G-50, and N-formyl-methionyl-leucyl-phenylalanine   
(fMLP) were from Sigma (St Louis, MO, USA). Recom-
binant human TFF3 (purity 98%) and TFF3-conjugated 
cyanine 5 (TFF3-Cy5) were purchased from Beijing Yong 
Kang Jia Xin Science and Technology Development (Beijing, 
People’s Republic of China [PRC]) and freshly prepared in 
saline. All other chemicals were of analytical grade.
The human acute monocytic leukemia cell line THP-1 was 
from the American Type Culture Collection (Rockville, MD, 
USA), human brain microvessel endothelial cells (HBMECs) 
were from ScienCell (Carlsbad, CA, USA), and fetal 
bovine serum and Roswell Park Memorial Institute (RPMI) 
1,640 medium were from Invitrogen (Carlsbad, CA, USA).
cell culture
HBMECs were cultured on the upper chamber of a Tran-
swell® insert of purified collagen with endothelial cell 
medium containing 1% (v/v) endothelial cell-growth supple-
ment, 5% (v/v) fetal bovine serum, and 1% (v/v) penicillin/
streptomycin solution in a humidified CO2 incubator at 
37°C.18,19 A standard chemotactic factor, 10-7 M fMLP was 
placed in the lower chamber under the HBMEC monolayers 
to establish a chemotactic gradient for monocyte migration 
across BBB in vitro.19 The THP-1 cell line was maintained 
in RPMI 1640 media supplemented with 10% fetal bovine 
serum at 37°C in 95% humidity and 5% CO2 atmosphere.20
animals
Male imprinting control region mice (weighing 18–22 g 
upon arrival) and male Sprague Dawley rats (weighing 200–
220 g upon arrival) were housed at a constant temperature 
(23°C±2°C), in a 12-hour/12-hour light/dark cycle with free 
provision of food and water. All of the animal experiments 
were carried out in compliance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, 
and the procedures were approved by the Peking University 
Animal Use Committee (LA2012/21).
UPlc determination of TFF3
Ultraperformance liquid chromatography (UPLC) and 
ultraviolet spectrophotometry were used to determine the 
concentration of TFF3. The apparatus consisted of an Acquity 
UPLC® H-class series (Waters, Milford, MA, USA). Chro-
matographic separation was performed on a C18 column 
(Acquity UPLC HSS T3, 1.8 μm, 2.1×100 mm) at a detec-
tion wavelength of 214 nm. The mobile phase consisted   International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
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of 1‰ trifluoroacetic acid (phase A) and 1‰ trifluoroacetic 
acid–acetonitrile (phase B). The elution profile (1 mL/min) 
was as follows: 0–1 minutes, linear gradient from 80/20 to 
50/50 solvent A/solvent B; 1–2 minutes, linear gradient from 
50/50 to 25/75; 2–3 minutes, linear gradient from 25/75 to 
80/20 solvent A/solvent B; 3–5 minutes, isocratic elution 
comprised of 80/20 solvent A/solvent B. The elution rate 
was at 0.3 mL/minute at 30°C. Calibration standards were 
made at 10, 20, 40, 80, 160, 320 μg/mL for TFF3.
Preparation of liposomes
Liposomes were formulated with SPC, 2 mol% DSPE-PEG, 
1 mol% DSPG, and appropriate amounts of cholesterol, 
and prepared as described previously.21 Briefly, a mixture 
of phospholipids and cholesterol at an appropriate ratio 
were dissolved in 15 mL of chloroform. The chloroform 
was evaporated under a stream of nitrogen gas, and the 
sample was placed in a high vacuum overnight. The lipid 
film was rehydrated in 5 mL of phosphate-buffered saline 
(PBS; pH 7.4) by gentle mixing and heating. The newly 
formed multilamellar vesicles were subjected to a 500 W 
ultrasonic treatment for 2 minutes by a sonicator (JY92-2D; 
Xinzhi, Ningbo, Zhejiang, China), and was passed three 
times through an extruder (LF-1; Avestin, Ottawa, Canada) 
containing 100 nm polycarbonate filters. As a result, blank 
liposomes were obtained.
remote loading of TFF3 into liposomes
TFF3 was loaded by the pH-gradient method. Blank lipo-
somes obtained as already mentioned were passed through 
a Sephadex G-50 column equilibrated with PBS (pH 4.5) to 
exchange the external buffer (PBS, pH 7.4). Then, the eluted 
liposomes had a transmembrane pH gradient of pH 7.4 inside 
and pH 4.5 outside. TFF3 was added to the liposome suspen-
sion at a modest lipid-to-drug molar ratio and then incubated 
with liposomes at 37°C for 2 hours for remote loading.22 To 
remove the unencapsulated TFF3, the liposome suspensions 
were passed through a mini-Sephadex G-50 column. Dif-
ferent molar ratios of lipid to drug or lipid to cholesterol, 
concentration of lipid, and PBS were optimized to obtain a 
satisfactory entrapment efficiency (EE) and average particle 
size. The equation for calculating the EE was as follows:
  EE = Winterior/Wtotal ×100%,  (1)
where Winterior represented the intraliposomal content of 
TFF3, and Wtotal represented the total content in the liposomal 
suspension when Triton X-100 was added to the suspension. 
A mini-Sephadex G-50 column was used to separate free 
drug for the calculation of Winterior.
For the preparation of fluorescent liposomes, TFF3-Cy5 
was used instead of TFF3 (TFF3-Cy5-Ls). As a control, 
neutrally charged liposomes loaded with TFF3 (TFF3-NLs) 
or TFF3-Cy5 (TFF3-Cy5-NLs) without addition of DSPG in 
the lipid formulation were prepared as mentioned earlier.
evaluation of characterization of TFF3-ls
The negatively charged liposomes (TFF3-Ls, TFF3-Cy5-Ls, 
and blank liposomes) and neutrally charged liposomes 
(TFF3-NLs and TFF3-Cy5-NLs) were observed by transmis-
sion electron microscopy (JEM-2010F, JEOL, Tokyo, Japan) 
following negative staining with 1% uranyl acetate solution. 
The average particle size and zeta potential of these five 
liposomes were determined by dynamic light scattering using 
a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). 
The EE of neutrally charged liposomes prepared according 
to the optimized formulation (SPC instead of DSPG) was 
assayed to compare with negatively charged liposomes. 
The stability of TFF3-Ls and TFF3-NLs was evaluated by 
determining the total TFF3 content in liposomes when Triton-
100 was added within 12 hours. As a control, the stability of 
TFF3 in PBS was also evaluated by determining the TFF3 
concentration in PBS.
Targeting mechanism investigation
For studying the binding ability of liposomes with mono-
cytes, THP-1 was used as the model of monocytes.23 Different 
lipid concentrations of TFF3-Cy5-Ls were added to THP-1 
for 1 hour’s incubation at 37°C. TFF3-Cy5 solutions of 
equivalent TFF3 concentrations were added to THP-1. As a 
control, TFF3-Cy5-NLs without the addition of DSPG were 
used. After incubation, nonadherent liposomes or TFF3-Cy5 
was removed by centrifugation. The stained THP-1 was 
subjected to an ultrasonic treatment for Cy5 fluorescence 
assay with a microplate reader (Thermo Fisher Scientific, 
Waltham, MA, USA).
For the targeting study in vitro, TFF3-Cy5 solution, TFF3-
Cy5-NLs, and TFF3-Cy5-Ls were separately added onto 
HBMECs in the presence of THP-1 cells for 1, 2, or 3 hours’ 
incubation at 37°C. After incubation, the suspension in the 
lower chamber was collected and subjected to an ultrasonic 
treatment for Cy5 fluorescence assay by microplate reader.
Tail-suspension test in mice
The tail-suspension test (TST) was performed according 
to a previous publication.24 Briefly, mice were suspended International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
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50 cm above the floor by adhesive tape placed approximately 
1 cm from the tip of the tail. The test was videotaped, and 
immobility time was measured for 6 minutes. Immobility 
was defined as the absence of any limb or body movements, 
with the exception of those caused by respiration, when the 
mice hung passively and completely motionless. During 
the test, the mice were separated from each other to prevent 
visual and acoustic associations. The number of seconds 
spent immobile was recorded. Observers were blind to the 
group treatment of the mice.
Forced-swim test in mice
The forced-swim test (FST) was similar to a previous 
protocol.25 Mice were placed in a 20 cm-diameter × 35 cm- 
height plastic cylinder filled to 20 cm with 23°C–25°C water. 
The test was videotaped, and immobility time was measured. 
The definition of immobility was the absence of all move-
ment, with the exception of motions required to maintain 
the animal’s head above the water. The results are expressed 
as the time spent immobile during the last 4 minutes of the   
6 minutes session. Observers were blind to the group treat-
ment of the mice.
locomotor activity in mice
Locomotor activity was measured using the open-field test 
(OFT). Briefly, the apparatus consisted of a 25 cm-diameter 
×12 cm-height circular arena divided into six equal squares 
on the floor of the arena. Mice were placed individually in the 
center of the cage, and the number of crossings to adjacent 
squares was counted as horizontal locomotor activity, and 
the total distance traveled (mm) was measured by computer 
for 5 minutes. Observers were blind to the group treatment 
of the mice.
Forced-swim test in rats
The rat FST was similar to a protocol used previously.26,27 
Briefly, the rats were placed for 15 minutes into a 25 cm-
diameter ×65-cm-height plastic cylinder filled to a depth of 
45 cm with 23°C–25°C water. The rats were then removed, 
dried, and returned to their home cage. They were placed 
again in the cylinders 24 hours later, and a 5-minute swim 
test was conducted and videotaped. Immobility was defined 
as the minimum movement required passively to keep the 
animal’s head above the water without other motions. Climb-
ing was defined as the upward-directed movement of the 
forepaws against the wall. The results are expressed as the 
time (in seconds) that the animals spent immobile during 
the 5-minute test.
locomotor activity in rats
Locomotor activity in rats was measured in the OFT. Briefly, 
the open-field apparatus is a square arena consisting of a 
75×75×40 cm square arena that was divided into 25 equal 
squares (15×15 cm) on the floor. Each rat was placed in the 
center of the cage, and the number of crossings (entering 
the adjacent square line) was counted for 5 minutes to assay 
the locomotor activity.
Results
UPlc assay
UPLC images of TFF3-Ls and blank liposomes (Figure 1) 
show that the endogenous interferences had no effect on 
the separation of TFF3. The calibration curves for TFF3 
were linear from 10 to 320 μg/mL (r=0.9997), with over-
all mean recoveries above 97.6%. The equation for TFF3 
was y=0.0004x-0.2886, where y represented concentra-
tion of TFF3 and x represented peak area. Therefore, the 
quantification of TFF3 was performed under the UPLC 
condition.
Optimization of TFF3-ls
To obtain high EE, the influence of the different formula-
tion factors, including the ratio of lipid to drug and lipid to 
cholesterol, and concentration of lipid and PBS were inves-
tigated. The ratio of lipid to cholesterol of 5:1.5 (Figure 2A) 
obtained the highest EE, with a 150 nm particle size among 
three groups. A significant decrease in EE was observed when 
the ratio of lipid to cholesterol was at 5:1 or 5:2 compared 
with 5:1.5. This might have resulted from the influence of 
cholesterol on the fluidity of the lipid bilayer. Therefore, a 
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modest content of cholesterol is necessary for the lipid for-
mulation.28 Considering 150 nm particle size was suitable for 
uptake by monocyte,9 the ratio of 5:1.5 lipid to cholesterol 
was chosen in the present study.
The EE exhibited a tendency to increase with the rising of 
lipid to drug, while the average particle size did not show a 
significant change. There was no significant difference in EE 
between 20:1 and 20:2. Considering the loading efficiency, 
the ratio of 20:2 was preferred (Figure 2B).
The concentration of lipid had no effect on the EE but 
significantly influenced the average particle size (Figure 2C). 
About 150 nm average particle size was obtained when the 
concentration of lipid was up to 10–15 mg/mL while a 105 nm   
particle size was obtained at 5 mg/mL. High lipid concentra-
tion would have led to an aggregation of liposome, which 
resulted in an increase in particle size. Given the possibility 
that precipitation might occur at high lipid concentration, 
10 mg/mL lipid concentration was preferred.
The high concentration of PBS induced an obvious 
instability in particle size (rising up to 200 nm) and decrease 
in EE (Figure 2D). As such, 10 mmol/L of PBS concentration 
was adopted in the formulation. Taken together, 5:1.5 lipid 
to cholesterol, 10:1 lipid to drug, 10 mg/mL lipid concentra-
tion, and 10 mmol/L PBS were used in the final formulation. 
According to the optimized formulation, 44.47% EE was 
obtained for TFF3-Ls.
characteristics of TFF3 liposomes
The average size and zeta potential of negatively charged 
liposomes (TFF3-Ls, TFF3-Cy5-Ls, and blank liposomes) 
and neutrally charged liposomes (TFF3-NLs and TFF3-Cy5-
NLs) are shown in Table 1. There was no obvious difference 
in average size for TFF3-Ls, TFF3-NLs, TFF3-Cy5-Ls, 
TFF3-Cy5-NLs, or blank liposomes. The zeta potential 
of negatively charged liposomes was much lower than that 
of neutrally charged liposomes, resulting from the   addition 
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of DSPG in lipid formula. The representative electron 
micrographs of negatively charged liposomes and neutrally 
charged liposomes are shown in Figure 3. Large unilamel-
lar vesicles were observed in micrographs. The EE did not 
show any significant differences among those five TFF3 
liposomes. Therefore, the loading of TFF3 and the addition 
of fluorescence lipid or DSPG had no influence on modality, 
EE, or particle size of liposomes.
In the stability study, TFF3 concentration showed no 
significant change for either TFF3-Ls or TFF3-NLs within 
12 hours (Figure 3F). Compared with the TFF3 solution, 
the stability of TFF3 was greatly enhanced by loading into 
negatively charged liposomes or neutrally charged liposomes. 
As a result, satisfactory negatively charged liposomes were 
obtained in this study.
Targeting mechanism investigation
As shown in Figure 4, the fluorescence strength of TFF3-
Cy5-Ls was the strongest among the three groups and 
increased with concentration. It suggested that the binding of 
TFF3-Cy5-Ls with monocytes was significantly stronger than 
that of TFF3-Cy5-NLs. TFF3-Cy5 did not bind with mono-
cytes. Negatively charged liposomes greatly enhanced the 
binding capacity of liposomes with monocytes. Furthermore, 
the fluorescence strength of migrated TFF3-Cy5-Ls was 
the strongest among those groups after 3 hours’ incubation 
(Figure 5). This suggested that negatively charged liposomes 
carried macromolecular drug across the BBB because of the 
high binding capacity with monocytes. TFF3-Cy5 could not 
cross the BBB regardless of whether it was by itself or in the 
presence of THP-1.
antidepressant-like effects of acute  
TFF3 administration in mice
Mice receiving saline, TFF3, TFF3-NLs, or TFF3-Ls were 
injected (intraperitoneally) 30 minutes before the TST 
(n=8 per group), respectively. Compared with the saline 
group, significant change was observed for both TFF3-Ls 
Table 1 The characteristics of various TFF3 liposomes
Blank liposome TFF3-Ls TFF3-NLs TFF3-Cy5-Ls TFF3-Cy5-NLs
Particle size (nm) 136.7 (PDI 0.161) 129.6 (PDI 0.185) 130.6 (PDI 0.112) 127.3 (PDI 0.132) 138.5 (PDI 0.117)
Zeta potential (mV) -32.7 -36.6 -12.9 -34.5 -15.6
ee (%) – 44.47 44.23 42.16 43.26
Abbreviations: TFF3-cy5-ls, trefoil factor 3-cyanine 5-loaded negatively charged liposomes; TFF3-cy5-Nls, TFF3-cy5-loaded neutrally charged liposomes; ee, entrapment 
efficiency; PDI, polydispersity index; TFF3-Ls, negatively charged liposomes loaded with TFF3; TFF3-NLs, neutrally charged liposomes loaded with TFF3.
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(P0.001) and TFF3-NLs (P0.01), while the TFF3 solu-
tion showed no significant change. The data showed that 
TFF3-NLs (P0.01) and TFF3-Ls (P0.05) produced 
stronger antidepressant-like effects compared with the TFF3 
solution, as measured by the decreased immobility time. 
TFF3-Ls (P0.01) was more effective than TFF3-NLs 
(Figure 6, A and B).
Additionally, acute TFF3-NL (P0.01) and TFF3-L 
(P0.001) administration also reduced the immobility 
time in the FST compared with the saline group, while no 
significant change was observed for the TFF3 solution. 
Furthermore, TFF3-Ls were more effective than TFF3-NLs 
(Figure 6, C and D). However, TFF3, TFF3-NL, or TFF3-L 
treatment did not affect the normal locomotion, as indicated 
by crossings (Figure 6, E and F) and total distance traveled 
in the OFT (Figure 6G).
We further determined the potential antidepressant-
like effect of TFF3, TFF3-NLs, and TFF3-Ls in rats. Four 
groups of rats (n=8 per group) were treated with saline, 
TFF3, TFF3-NLs, or TFF3-Ls 30 minutes before the 
FST (Figure 7A). The analysis data showed that acute 
TFF3-NL (P0.05) and TFF3-L (P0.01) administration 
significantly decreased immobility time in the FST com-
pared with the saline group, and no significant decrease 
in immobility time was observed for the TFF3 solution. 
TFF3-Ls were more effective than TFF3-NLs (Figure 7B).   
We also found that acute TFF3-NL (P0.001) and TFF3-L 
(P0.001) administration significantly increased swim-
ming time in the FST, and the TFF3 solution showed no 
effect on swimming time. The antidepressant-like effects of 
TFF3-Ls (P0.01) was stronger than TFF3-NLs (Figure 7B).   
The TFF3 solution had no influence on swimming time. More-
over, four separate groups of rats treated with saline, TFF3, 
TFF3-NLs, or TFF3-Ls were used to measure locomotor activ-
ity in rats (Figure 7D). The results showed that acute TFF3, 
TFF3-NLs, and TFF3-Ls did not affect normal locomotion, 
reflected by the number of crossings in the OFT (Figure 7E). 
This suggested that reductions in immobility and increases 
in swimming were not attributable to alterations in locomo-
tor activity. These results suggest that acute TFF3 solution 
administration did not produce an antidepressant effect; the 
antidepressant behavioral effects of TFF3 were enhanced by 
loading into liposomes; negatively charged liposomes showed 
more effective antidepressant effect resulting from the obvious 
brain-targeting effect.
Discussion
It is now known that the brain is under immunological sur-
veillance, and thus phagocytic cells of the innate immune 
system, mainly neutrophils and monocytes, can be exploited 
as transporters of drugs to the brain. In a previous study, 
monocytes were believed to be the main contributor in this 
targeting drug-delivery system.10 Therefore, the main aim 
of this study was to enhance the affinity of liposomes with 
monocytes.
It has been reported that negatively charged liposomes 
that are not of a ultrasmall size will result in efficient uptake 
by phagocyte cells (monocytes and neutrophils). These lipo-
somes are rapidly cleared by blood monocytes, neutrophils, 
and macrophages of the liver, spleen, and bone marrow. 
Drug was transported across the BBB by the phagocyte cells 
and subsequently released from these cells in the brain.10 
  Therefore, negatively charged liposomes with proper par-
ticle size were the key factors in this targeting drug-delivery 
system. In the present study, a negatively charged liposome 
of about 130 nm particle size was obtained. Comparing with 
neutrally charged liposomes, they showed a greatly higher 
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binding ability with monocytes and obtained an obvious 
migration across the BBB in vitro and in vivo.
Incorporation of liposomes into protein formulations for 
drug-delivery systems may represent an attractive method for 
sustained release, reducing the degradation and enhancing the 
pulmonary permeation rate.22 The engineering of an effective 
liposomal drug formulation for drug delivery must take into 
consideration encapsulation efficiency, vesicle stability, and 
the leakage problem associated with the delivery process.29 
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techniques of effective drug loading in vesicles that retain 
their stability in the biological milieu and exhibit optimal 
body-distribution profiles. The dehydration–rehydration 
method and pH-gradient method were often used, followed 
or not by repeated extrusion.16 In the present study, TFF3 
was efficiently loaded into preformed liposomes and high 
EE was obtained by the pH-gradient method. Furthermore, 
liposomes significantly enhanced the stability of TFF3, which 
might contribute to targeting delivery and the increased 
antidepressant-like effect.
THP-1 cells have become one of most widely used cell 
lines to investigate the function and regulation of monocytes. 
The interactions between THP-1 cells and various vascu-
lar cells (such as endothelial cells, smooth-muscle cells, 
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adipocytes, and T cells) provide insight into the roles of the 
interconnection of monocytes and macrophages with other 
vascular cells during vascular inflammation.23 Technically, 
THP-1 cells have some advantages over human primary 
monocytes and macrophages. Their homogeneous genetic 
background minimizes the degree of variability in the cell 
phenotype. This trait is particularly important when studying 
the biological function of chemicals with high variability. 
Furthermore, THP-1 cells can be stored indefinitely in liq-
uid nitrogen. Following an appropriate procedure, this cell 
line can be recovered without obvious detrimental effect on 
monocyte/macrophage features or cell viability. This ability 
to store cells guarantees sufficient cells for deoxyribonucleic 
acid, ribonucleic acid, biometal, and protein studies. In 
contrast, the availability of primary human monocytes and 
macrophages is limited, accounting for only 3%–9% of all 
leukocytes.30,31 Therefore, in this study, THP-1 was very suit-
able to study the combination of monocytes with liposomes. 
HBMECs are a well-established in vitro model of the human 
BBB that constitutively expresses adhesion molecules rela-
tive to monocyte migration across the BBB. The chemotactic 
gradient of fMLP was used to attract monocytes to migrate 
across the BBB.19 As a result, HBMECs and THP-1 were used 
as the model to investigate the targeting effect of liposomes 
with monocytes crossing the BBB.
The TST and FST are two widely used behavioral mod-
els in rodents used to assess putative antidepressant com-
pounds. The increased immobility time in animals reflects 
the desperate behavior usually seen in depressed patients. 
Medications that can reduce the immobility time in the TST 
and FST reflect a potential antidepressant-like activity, such 
as   conventional antidepressant drugs and electroconvulsive 
therapy. The increased swimming time that animals spend in 
the FST indicates the ability to escape actively from stressful 
events. Therefore, the score of swimming time was another 
useful indicator for the therapeutic benefits of possible agents 
in the treatment of depression and stress-related disorder. We 
found here that TFF3-Ls decreased immobility in both the 
TST and FST in mice, and increased swimming time in the FST 
of rats, suggesting that TFF3-Ls could be used for the therapy 
of behavioral dysfunctions in a model of desperate animals. 
Furthermore, in the present study, to exclude the possibility 
that the antidepressant-like effects of TFF3-NLs and TFF3-Ls 
were attributable to stimulatory effects on locomotor func-
tion, we evaluated TFF3-induced spontaneous activity in the 
OFT. The results showed that mice treated with TFF3-NLs 
and TFF3-Ls exhibited no alterations in spontaneous activity 
in the OFT, indicating that the decreases in immobility in 
the FST and TST were induced by increases in active move-
ments, such as struggling and swimming, but not caused 
by motor stimulation. Furthermore, our data also showed 
that acute systemic TFF3-L administration exerted stronger 
antidepressant-like properties than TFF3-NLs in the rat FST 
and in the mouse TST and FST, as reflected by decreased 
immobility and increased swimming time, suggesting that 
negatively charged liposomes enhanced the effective delivery 
of TFF3 solution across BBB.
Conclusion
In the present study, negatively charged liposomes were 
prepared by the addition of DSPG, and a high EE of TFF3 
was obtained by a remote-loading method. The TFF3-Ls 
showed an excellent ability to migrate across the BBB as a 
result of high binding efficiency with THP-1. Subsequently, 
an enhanced antidepressant-like effect of TFF3 loaded into 
negatively charged liposomes was obtained in animal models 
of depression. These findings provide prospective insights 
into the development of TFF3-Ls as a potential antidepressant 
drug relative to clinically used antidepressants.
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